MARBOFLOXACIN
Chemical Name | 9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-piperazino)-7-oxo-7H-pyrido[1,2,3-ij][1,2,4]benzoxadiazine-6-carboxylic acid |
CAS Number | 115550-35-1 |
Molecular Formula | C17H19N4O4F |
Molecular Weight | 362.36 |
MolecularStructure | |
Packing | 25kg/Drum |
Capacity | 8000kg/ Year |
Storage | Sealed tightly and stored away from light in a cool and dry place |
Application | Marbofloxacin can be used both orally and topically. It is particularly used for infections of the skin,respiratory system and mammary glands in dogs and cats, as well as with urinary tract infections. |
SPECIFICATION
Items | Specification |
Appearance | Light yellow,crystalline powder |
Identification | Should comply with the RS IR absorption spectrum |
Absorbance | ≤0.20 |
Impurity A | ≤0.1% |
Impurity B | ≤0.1% |
Impurity C | ≤0.2% |
Impurity D | ≤0.2% |
Impurity E | ≤0.2% |
Unspecified impurities | ≤0.2% |
Total impurities | ≤0.5% |
Heavy metals | ≤20 ppm |
Loss on drying | ≤0.5% |
Sulfated ash | ≤0.1% |
Assay (Dried substance) | 99.0~101.0%% |
Ethanol | ≤5000 ppm |
Dichloromethane | ≤600 ppm |
Standard | EP 7.0 |